Latest Breaking News On - Week results - Page 2 : comparemela.com

Highlanders Royals midfielder over the moon

Bringing you the best

Kettina jupaQueen lozikeyiGerald sibandaLas palmasZimbabwe women super leagueZimbabwe women soccer leagueZimbabwe womenSuper leagueWestern rangersLoxion vipersNew orleansBorrow jetsWeek resultsCity queensUbuntu queensHighlanders royals

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

South koreaFrance generalSan diegoUnited statesSloan simpsonMichael meoRichard jarvisZain iqbalMarlena abdinoorImke kappesNicole zinsli sommAnn hematolSamir shahParag mahantiIptacopan monotherapySatoshi sugimoto

CT-P43 Shows Equivalent Efficacy, Safety for Plaque Psoriasis vs Ustekinumab

Data from a phase 3 trial of CT-P43 in patients with moderate to severe plaque psoriasis offers additional insight into the comparative effects of the biosimilar relative to ustekinumab.

South koreaRepublic of koreaKim pappProbity medical research incEuropean medicines agencyDrug administrationArcutis therapeuticsEuropean union sourcedPsoriasis areaSeverity indexGlobal assessmentCandidate biosimilarOriginator ustekinumabIsevere plaque psoriasisWeek results

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesIsabella zinckJulie masowSamir shahRichard jarvisParag mahantiMarlena abdinoorNicole zinsli sommImke kappesSloan simpsonSatoshi sugimotoMichael meoJeff legosZain iqbalJonathan grahamIptacopan monotherapy

Press Release: Novartis showcases significant data updates from Kisqali(R), iptacopan and Scemblix(R) at SABCS and ASH

Press Release: Novartis showcases significant data updates from Kisqali(R), iptacopan and Scemblix(R) at SABCS and ASH
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United statesJakavir ruxolitinibJeff legosIptacopan monotherapyGlobal head of oncology development at novartisAmerican society of hematologyAntonio breast cancer symposiumAmerican societyAnnual meetingExecutive vice presidentGlobal headOncology developmentPoster sessionDisease abstract titleFactorb inhibitionSustained long term efficacy